VTVT
vTv Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.80
+1.27%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.16
- Revenue estimate
- $333.3K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.05
- EPS estimate
- -$0.97
- Revenue actual
- —
- Revenue estimate
- $333.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +103.1%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $50
- PT range
- $42 – $57
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.97 | -$1.05 | Miss -8.25% | — |
| May 13, 2026 | $0.34 | $1.65 | Beat 385.29% | $36.8M |
| Mar 10, 2026 | -$1.09 | -$0.58 | Beat 46.69% | -$24.0K |
| Nov 6, 2025 | -$0.97 | -$1.08 | Miss -11.34% | — |
| Aug 12, 2025 | -$0.85 | -$0.92 | Miss -8.24% | — |
| May 15, 2025 | -$0.73 | -$0.77 | Miss -5.48% | — |
| Mar 20, 2025 | -$0.87 | -$0.55 | Beat 36.78% | $17.0K |
| Aug 8, 2024 | -$3.20 | -$0.81 | Beat 74.69% | — |
| May 9, 2024 | -$3.20 | -$1.17 | Beat 63.44% | $1.0M |
| Mar 13, 2024 | -$2.80 | -$1.67 | Beat 40.36% | -$9.0K |
| Nov 9, 2023 | -$3.20 | -$3.20 | In line | — |
| Aug 11, 2023 | -$0.07 | -$2.80 | Miss -3900.00% | $9.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026